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Abstract
Background: Parents of young children are responsible for daily type 1 diabetes (T1DM) cares including insulin bolusing.
For optimal insulin pump management, parents should enter a blood glucose result (SMBG) and a carbohydrate estimate (if
food will be consumed) into the bolus advisor in their child’s pump to assist in delivering the recommended insulin bolus.
Previously, pump adherence behaviors were described in adolescents; we describe these behaviors in a sample of young
children.
Methods: Pump data covering between 14-30 consecutive days were obtained for 116 children. Assessed adherence to
essential pump adherence behaviors (eg, SMBG, carbohydrate entry, and insulin use) and adherence to 3 Wizard/Bolus
Advisor steps: SMBG–carbohydrate entry–insulin bolus delivered.
Results: Parents completed SMBG ≥4 times on 99% of days, bolused insulin ≥3 times on 95% of days, and entered
carbohydrates ≥3 times on 93% of days, but they corrected for hyperglycemia (≥250 mg/dl or 13.9 mmol/l) only 63% of the
time. Parents completed Wizard/Bolus Advisor steps (SMBG, carbohydrate entry, insulin bolus) within 30 minutes for 43% of
boluses. Inverse correlations were found between children’s mean daily glucose and the percentage of days with ≥4 SMBG
and ≥3 carbohydrate entries as well as the percentage of boluses where all Wizard/Bolus Advisor steps were completed.
Conclusions: Parents of young children adhered to individual pump behaviors, but showed some variability in their adherence
to Wizard/Bolus Advisor steps. Parents showed low adherence to recommendations to correct for hyperglycemia. Like
adolescents, targeting pump behaviors in young children may have the potential to optimize glycemic control.
Keywords
adherence, bolus calculator software, preschool-age children, insulin pumps, type 1 diabetes mellitus
Many families of young children (≤6 years) with type 1 diabetes mellitus (T1DM) are choosing to use a pump for insulin management.1,2 Specifically, registry data from the
Prospective Diabetes Follow-up Registry (DPV) in Europe
suggest about 74% of young children are using a pump,
while in the United States, the T1 Diabetes Exchange suggests about 50% of young children are using a pump.1 For
young children in particular, insulin pumps present a number
of distinct advantages to injections, including the ability to
deliver very small doses of insulin, to deliver multiple doses
without a need for multiple needle sticks, and if needed, to
temporarily suspend insulin in the event of hypoglycemia.3,4
Another advantage to insulin pumps is the bolus advisors,
which several pumps contain and which can alleviate the burden associated with calculating a child’s insulin bolus doses.5,6
These bolus calculators use algorithms that account

for a multitude of variables including the child’s current
“insulin-on-board” (ie, the remaining bolus insulin in the
body), current blood glucose level, target blood glucose level,
the amount of carbohydrates to be consumed, the child’s
insulin-to-carbohydrate ratio, and an approximation of the
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insulin action curve. It has been shown that using the bolus
advisor can improve glycemic control.5-7 However, its use
requires 2 essential pieces of information: the child’s current
blood glucose level and the number of grams of carbohydrates to be consumed, if a meal/snack is planned.5 Previous
research in older youth with T1DM revealed some inconsistency in the percentage of days where youth inputted blood
glucose values and carbohydrate amounts into their Medtronic
pump and in the number of days where youth bolused at least
3 times.5 This study also found that youth completed all 3
Medtronic Wizard steps (viz, entered a glucose, entered a carbohydrate amount, and received a bolus) within 30 minutes
for only 29% of boluses, which is suboptimal.5 However,
because the study did not include children less than 7 years
old, it is not known if similar challenges to insulin pump
adherence behaviors exist for parents of young children.
Therefore, our aim was to describe the insulin pump adherence behaviors that are required for optimal bolus advisor use
in families of young children with T1DM and to relate these
behaviors to children’s daily glycemic control and glycated
hemoglobin (HbA1c). If found to be correlated with glycemic
control, our results would suggest that intervening to improve
parents’ pump adherence behaviors may be another pathway
to better child health outcomes.

≥250 mg/dl, based on methodology established by Driscoll
et al.5 In addition, we determined the percentage of time
pumps recorded a combination of optimal pump behaviors
using modified software developed by Driscoll and colleagues. Children’s HbA1c values were originally obtained
for clinical management using the Tosoh G8 HPLC Analyzer
(Tosoh Bioscience Inc, San Francisco, CA, USA). We calculated children’s mean daily blood glucose values using the
SMBG data collected directly from children’s glucometers.
Finally, we calculated a mealtime insulin BOLUS score for
children,8 which is a valid measure of adherence to mealtime
insulin use, to compare with the other pump measures developed by Driscoll et al.5

Methods

Young children had a mean age of 5.2 ± 1.4 years (range:
0.27-6.94 years), a mean HbA1c of 8.2 ± 1.4% (6.20-13.30)
and a mean daily blood glucose level of 208 ± 49 mg/dl
(range: 132-381). There were 65 boys. Of children, 85%
were identified by their parents as White and 4% were identified as Hispanic/Latino. Children had a mean time since diabetes diagnosis of 1.62 ± 1.77 years. The majority of children
included in the sample used a Medtronic insulin pump (83%).

This study used deidentified data extracted from the MERCY
on TODP database, a health outcomes repository containing
data on over 5900 patients receiving care at Children’s Mercy
Hospital-Kansas City from 1993-present, including insulin
pump downloads from 2007-present. The inclusion criteria
were (1) children between the ages of 0 and 6.99 years old,
(2) a minimum of 14 consecutive days of insulin pump data,
and (3) a corresponding HbA1c level matched to their insulin
pump data. These criteria yielded a sample of 116 young
children, all of whom had a confirmed diagnosis of T1DM
for at least 3 months prior to the date of data extraction. We
obtained institutional approval for this study before any data
were retrieved. The Institutional Review Board granted a
waiver of written informed consent for the present study in
accordance with 45 CFR 164.512(i)(1)(i).

Procedure
The specific data extracted included demographics (ie, child
age, sex, race/ethnicity, and duration of diabetes), between
14-30 consecutive days of insulin pump/glucometer data
randomly selected for each participant, and an HbA1c level
collected within 15 days following the available pump data.
These data were imported into a spreadsheet to calculate the
percentage of days with ≥4 SMBG checks, the percentage of
days with ≥3 carbohydrate inputs, the percentage of days
with ≥3 insulin boluses administered, and the percentage of
times insulin was administered for a blood glucose level

Analyses
We used means, standard deviations, and frequency counts to
evaluate children’s demographics, HbA1c, mean daily blood
glucose, and their pump behaviors. We ran simple correlations to associate children’s adherence scores and pump
behaviors with their HbA1c and mean daily blood glucose
levels.

Results

Individual Pump Adherence Behaviors
We used all available data to evaluate young children’s pump
behaviors and BOLUS scores. Children had a mean of 24 ± 6
days of data captured. Overall, parents showed greater than
or equal to 90% adherence to the percentage of days with ≥4
SMBG checks, the percentage of days with ≥3 carbohydrate
inputs, and the percentage of days with ≥3 insulin boluses
administered. In contrast, parents corrected for glucose levels ≥250 mg/dl only 63% of the time. Children’s BOLUS
score suggests that they may either miss a meal, consume a
meal outside of typical mealtimes, or miss bolusing for a
meal approximately 1 time every 3 days.
Table 1 reports the correlations between children’s HbA1c
and mean daily blood glucose levels with their general pump
behaviors and BOLUS scores. Children’s mean daily blood
glucose level was significantly inversely related to their
BOLUS score (r = –.293, P = .01), the percentage of days
with ≥4 SMBG checks (r = –.220, P = .05), and the percentage of days with ≥3 carbohydrate inputs (r = –.274, P = .01).
However, their HbA1c level was significantly inversely
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Table 1. Correlations Between Measures of Children’s Glycemic Control and Pump Adherence Behaviors.

1. Mean daily glucose level
2. HbA1c
3. Age
4. BOLUS score
5. %
 days BG ≥ 4
6. % days CHO ≥ 3
7. %
 days insulin ≥ 3
8. %
 bolus ≥ 250 mg/dl (13.9 mmol/l)

1

2

3

4

5

6

7

8

1

.498**
1

−.029
−.168
1

−.293**
−.389**
−.053
1

−.220*
−.177
−.062
.079
1

−.274**
−.366**
.059
.565**
.513**
1

.054
.018
.324**
.285**
.094
.484**
1

.073
−.060
.252*
.058
−.153
.080
.055
1

*P < .05. **P < .01.

Table 2. Correlations Between Children’s Glycemic Control and Combined Wizard/Bolus Advisor Adherence Behaviors.

1. M
 ean daily glucose level
2. HbA1c
3. All 3 steps (SMBG+ carbohydrate entry + insulin bolus)
4. SMBG + insulin bolus (no carbohydrate entry)
5. Carbohydrate entry + insulin bolus (no SMBG)

1

2

3

4

5

1

.498**
1

−.227*
−.041
1

.451**
.218*
−.232*
1

.039
−.049
−.909**
−.194*
1

*P < .05. **P < .01.

correlated only with their BOLUS score (r = –.389, P = .01)
and their percentage of days with ≥3 carbohydrate inputs (r =
–.366, P = .01). Other general pump behaviors did not correlate with children’s mean daily blood glucose or HbA1c
levels. Overall, older child age was associated with an
increase in the frequency of days with ≥3 insulin boluses
administered (r = .324, P = .01) and an increase in the number of times parents corrected for glucose levels ≥250 mg/dl
(r = .252, P = .05).

Combined Wizard/Bolus Advisor Steps (ie,
Combined Pump Adherence Behaviors)
We calculated the mean percentages of the events when all
combinations of Wizard/Bolus Advisor steps were performed
within 30 minutes. Families entered an SMBG check and
carbohydrate units and completed an insulin bolus within 30
minutes for 43 ± 28% of boluses, they entered an SMBG
check and completed a bolus (no carbohydrate units entered)
within 30 minutes for 14 ± 12% of boluses, and they entered
carbohydrate units and completed a bolus (no SMBG
entered) within 30 minutes for 42 ± 27% of boluses. Notably,
there were no recorded episodes where families administered
an insulin bolus without either entering an SMBG or carbohydrate units. There was recorded a very low frequency of
episodes where parents entered only an SMBG into their
child’s insulin pump (0.2 ± 1%), recorded only carbohydrate
units into their child’s insulin pump (0.04 ± 0.02%), or
recorded an SMBG and carbohydrate units into their child’s
insulin pump, with no insulin administered (0.01 ± 0.01%).

We found an inverse relation between the percentage of
boluses with all 3 bolus advisor steps (viz, SMBG and carbohydrate entries, insulin administered) completed and children’s mean blood glucose levels (r = –.227, P < .05; Table 2).
There was a direct relation between the percentage of boluses
with only an SMBG entry (r = .451, P < .001) and children’s
mean daily blood glucose. We further found that the percentage of boluses with only an SMBG entry was directly associated with children’s HbA1c (r = .218, P < .05). Other
combinations of wizard steps did not correlate with either
children’s mean daily blood glucose or HbA1c levels.

Discussion
This study extends the existing literature because it focuses
on young children, who were previously left out of studies
examining youth’s pump adherence behaviors.5,6 Overall,
families of young children showed higher rates of adherence
to checking SMBG, insulin use, and inputting carbohydrates
into the pump than older children and adolescents.5 However,
families of young children showed a relatively low rate of
correcting for glucose levels >250 mg/dl (63%) and this variable correlated with children’s age, suggesting that parents of
the youngest children may be even less likely to correct for
glucose values >250 mg/dl. In young children, the percentage of days with ≥4 SMBG checks and the percentage of
days with ≥3 carbohydrate entries correlated with lower
mean daily blood glucose levels. There was also an inverse
correlation between the percentage of days with ≥3 carbohydrate entries and children’s HbA1c levels. But these results
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are inconsistent with previous findings in older children and
adolescents, which found inverse correlations between
youth’s HbA1c levels and all of the pump adherence behaviors.5 It is possible that we found different results for young
children because of their greater susceptibility to glycemic
variation than older children and adolescents.4,9,10
Specifically, we predict that we might not have seen associations between young children’s HbA1c levels and the percentage of days with ≥4 SMBG checks and percentage of
days with ≥3 bolus doses delivered because some of these
were entered to treat high blood glucose events, therefore
confounding any relation with children’s HbA1c levels.
Although not reported previously,5 in the present study we
also calculated a mealtime BOLUS score (ie, indicator of
adherence to mealtime insulin use).8 Young children’s
BOLUS scores inversely correlated with both their mean
daily blood glucose levels and their HbA1c levels, suggesting that dosing for insulin for meals is an important component of better glycemic control.
Consistent with the previous literature,5 our study examined families’ adherence to combined Wizard/Bolus Advisor
actions. In general, parents of young children showed better
adherence to completing all 3 of the Medtronic Wizard steps
within 30 minutes than older children and adolescents (43%
versus 29%, respectively).5 Interestingly, there was some
similarity across the 2 samples when examining for other
combinations of Medtronic Wizard steps. Specifically, older
children and adolescents entered a SMBG value and delivered insulin within 30 minutes (no carbohydrate unit entered)
for 18% of boluses,5 while families of young children did
this for 14% of boluses. Older children and adolescents
entered a carbohydrate unit and delivered insulin within 30
minutes (no SMBG entered) for 31% of boluses,5 while families of young children did this for 42% of boluses. This is a
troubling finding because if 30 minutes or more have elapsed
between the previous SMBG and the meal, the bolus calculator is likely using less accurate SMBG data to calculate an
insulin dose which could lead to more or less insulin administered than is needed. Across both samples, there were very
low rates of other suboptimal categories of combined Wizard/
Bolus Advisor actions, including a low percentage of boluses
where insulin only was administered (2.5% and 0% for older
children/adolescents and young children, respectively5),
which is reassuring because administering insulin without
entering a SMBG level or carbohydrate amount represents a
potentially dangerous self-care behavior.
Not surprising, we found that young children’s mean daily
blood glucose levels correlated inversely with the percentage
of boluses where all 3 Wizard/Bolus Advisor steps were
completed within 30 minutes. Completing all 3 Wizard/Bolus
Advisor steps represents an optimal level of adherence for
food-related boluses and should be closely related to children’s daily glycemic variability and control. Direct correlations were found for the percentage of boluses with a SMBG
entry and children’s mean daily glycemic control and HbA1c
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levels, which could relate to how parents are correcting for
high glucose values.
Our findings suggest that families of young children with
T1DM also could benefit from user-friendly reports that provide detailed statistics on their adherence to individual and
combined insulin pump behaviors (ie, Wizard/Bolus Advisor
actions), which might help families and providers to identify
new targets for intervention.5 In addition, these updated reports
might offer new insights into adherence behaviors that predict
children’s glycemic patterns. For example, in cases where a
young child shows a high percentage of boluses delivered with
a SMBG only, the diabetes team may be able to show the family how they are spending a great percentage of their effort
reacting to their child’s blood glucose levels versus adequately
dosing for insulin across the day. In addition, highlighting the
patterns associated with the percentage of time that high blood
glucoses are not followed by an insulin bolus (in the absence
of physical activity) may lead to discovering a family’s fear of
hypoglycemia, which may also be treatable.
Our study limitations include an inability to generalize
our findings to families of young children who come from
racial or ethnic backgrounds other than non-Hispanic white.
In addition, our clinic has a rate of insulin pump use that
exceeds the national average (83% versus 62%2). Therefore,
our results may not generalize to samples from clinics with
lower rates of pump use. By updating the software code, we
were not limited to young children on a Medtronic insulin
pump as in the previous study.5 However, our data were still
vulnerable to problems created by a frequent lack of wireless
communication between children’s glucometers and pumps
(ie, “linked meters”), problems with incorrect dates programmed into devices, and variation in the number of days
with available device data prior to an HbA1c measurement.
To prevent these problems, future studies should synchronize
the times and dates of children’s glucometers and insulin
pumps ahead of data collection and clearly specify the duration of data collection to ensure that a consistent number of
days are included. Finally, we used cross-sectional data collected 14-30 days before children’s regularly scheduled
clinic appointment. Previous research has shown a “whitecoat adherence” effect for SMBG frequency11 and pump
adherence behaviors12 for children immediately preceding a
diabetes clinic appointment, suggesting the possibility that
our data might actually overestimate adherence for some
families. Future research should consider a longitudinal
approach or collect data further out from children’s clinic
appointments to minimize this problem. In addition, it might
be helpful to examine children’s pump behaviors in relation
to continuous and/or flash glucose monitoring data as an
objective measure of glycemic control.

Conclusion
Similar to older children and adolescents, families of young
children do not always adhere to insulin pump behaviors,
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especially combined behaviors related to optimal Wizard/
Bolus Advisor use. Interventions that target families’ adherence to pump adherence behaviors may help young children
achieve optimal glycemic control and should be the focus of
future research. Likewise, we need to develop new clinical
reports that make it easier for families and providers to analyze pump adherence behaviors and engage in problem solving related to improving these behaviors.
Abbreviations
DPV, Prospective Diabetes Follow-up Registry; HbA1c, glycated
hemoglobin; SMBG, self-monitoring blood glucose; T1DM, type 1
diabetes mellitus.
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